N'-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-N-[2-[[5-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-6-(methylcarbamoyl)pyridazin-3-yl]amino]-2-oxoethyl]nonanediamide

C50H65N13O8S — CID 169087166

IUPACN'-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-N-[2-[[5-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-6-(methylcarbamoyl)pyridazin-3-yl]amino]-2-oxoethyl]nonanediamide
SMILESCNC(=O)c1nnc(NC(=O)CNC(=O)CCCCCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)c2ccc(-c3scnc3C)cc2)C(C)(C)C)cc1Nc1cccc(-c2ncn(C)n2)c1OC
InChIInChI=1S/C50H65N13O8S/c1-29(31-19-21-32(22-20-31)44-30(2)54-28-72-44)55-47(68)37-23-33(64)26-63(37)49(70)45(50(3,4)5)58-40(66)18-13-11-9-10-12-17-39(65)52-25-41(67)57-38-24-36(42(60-59-38)48(69)51-6)56-35-16-14-15-34(43(35)71-8)46-53-27-62(7)61-46/h14-16,19-22,24,27-29,33,37,45,64H,9-13,17-18,23,25-26H2,1-8H3,(H,51,69)(H,52,65)(H,55,68)(H,58,66)(H2,56,57,59,67)/t29-,33+,37-,45+/m0/s1
InChIKeyZSMRQGKTEUMASC-JZGYQPHTSA-N
MW1008.22 g/mol
LogP4.97
Rot. Bonds22

About N'-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-N-[2-[[5-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-6-(methylcarbamoyl)pyridazin-3-yl]amino]-2-oxoethyl]nonanediamide

N'-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-N-[2-[[5-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-6-(methylcarbamoyl)pyridazin-3-yl]amino]-2-oxoethyl]nonanediamide (PubChem CID 169087166) has the molecular formula C50H65N13O8S and a molecular weight of 1008.22 g/mol. Its IUPAC name is N'-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-N-[2-[[5-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-6-(methylcarbamoyl)pyridazin-3-yl]amino]-2-oxoethyl]nonanediamide.

Molecular Properties

Compound NameN'-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-N-[2-[[5-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-6-(methylcarbamoyl)pyridazin-3-yl]amino]-2-oxoethyl]nonanediamide
PubChem CID169087166
Molecular FormulaC50H65N13O8S
Molecular Weight1008.22 g/mol
Exact Mass1007.48
IUPAC NameN'-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-N-[2-[[5-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-6-(methylcarbamoyl)pyridazin-3-yl]amino]-2-oxoethyl]nonanediamide
SMILESCNC(=O)c1nnc(NC(=O)CNC(=O)CCCCCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)c2ccc(-c3scnc3C)cc2)C(C)(C)C)cc1Nc1cccc(-c2ncn(C)n2)c1OC
InChIInChI=1S/C50H65N13O8S/c1-29(31-19-21-32(22-20-31)44-30(2)54-28-72-44)55-47(68)37-23-33(64)26-63(37)49(70)45(50(3,4)5)58-40(66)18-13-11-9-10-12-17-39(65)52-25-41(67)57-38-24-36(42(60-59-38)48(69)51-6)56-35-16-14-15-34(43(35)71-8)46-53-27-62(7)61-46/h14-16,19-22,24,27-29,33,37,45,64H,9-13,17-18,23,25-26H2,1-8H3,(H,51,69)(H,52,65)(H,55,68)(H,58,66)(H2,56,57,59,67)/t29-,33+,37-,45+/m0/s1
InChIKeyZSMRQGKTEUMASC-JZGYQPHTSA-N
XLogP4.97
TPSA276.68 Ų
H-Bond Donors7
H-Bond Acceptors16
Rotatable Bonds22
Heavy Atoms72
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001008.22
LogP ≤ 54.97
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N'-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-N-[2-[[5-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-6-(methylcarbamoyl)pyridazin-3-yl]amino]-2-oxoethyl]nonanediamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N'-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-N-[2-[[5-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-6-(methylcarbamoyl)pyridazin-3-yl]amino]-2-oxoethyl]nonanediamide?
The IUPAC name of N'-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-N-[2-[[5-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-6-(methylcarbamoyl)pyridazin-3-yl]amino]-2-oxoethyl]nonanediamide (CID 169087166) is N'-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-N-[2-[[5-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-6-(methylcarbamoyl)pyridazin-3-yl]amino]-2-oxoethyl]nonanediamide.
What is the SMILES notation for N'-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-N-[2-[[5-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-6-(methylcarbamoyl)pyridazin-3-yl]amino]-2-oxoethyl]nonanediamide?
The canonical SMILES for N'-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-N-[2-[[5-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-6-(methylcarbamoyl)pyridazin-3-yl]amino]-2-oxoethyl]nonanediamide is CNC(=O)c1nnc(NC(=O)CNC(=O)CCCCCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)c2ccc(-c3scnc3C)cc2)C(C)(C)C)cc1Nc1cccc(-c2ncn(C)n2)c1OC.
What is the InChIKey of N'-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-N-[2-[[5-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-6-(methylcarbamoyl)pyridazin-3-yl]amino]-2-oxoethyl]nonanediamide?
The InChIKey is ZSMRQGKTEUMASC-JZGYQPHTSA-N. The full InChI is InChI=1S/C50H65N13O8S/c1-29(31-19-21-32(22-20-31)44-30(2)54-28-72-44)55-47(68)37-23-33(64)26-63(37)49(70)45(50(3,4)5)58-40(66)18-13-11-9-10-12-17-39(65)52-25-41(67)57-38-24-36(42(60-59-38)48(69)51-6)56-35-16-14-15-34(43(35)71-8)46-53-27-62(7)61-46/h14-16,19-22,24,27-29,33,37,45,64H,9-13,17-18,23,25-26H2,1-8H3,(H,51,69)(H,52,65)(H,55,68)(H,58,66)(H2,56,57,59,67)/t29-,33+,37-,45+/m0/s1.
What are the key properties of N'-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-N-[2-[[5-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-6-(methylcarbamoyl)pyridazin-3-yl]amino]-2-oxoethyl]nonanediamide?
N'-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-N-[2-[[5-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-6-(methylcarbamoyl)pyridazin-3-yl]amino]-2-oxoethyl]nonanediamide has a molecular weight of 1008.22 g/mol, XLogP of 4.97, 22 rotatable bonds, 7 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for N'-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-N-[2-[[5-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-6-(methylcarbamoyl)pyridazin-3-yl]amino]-2-oxoethyl]nonanediamide is sourced from PubChem (CID 169087166), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).